Sherlock Biosciences Mar 8, 2022 Sherlock Biosciences Raises $80M in Series B Financing May 11, 2021 Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests May 3, 2021 Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk Apr 21, 2021 Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests Jan 7, 2021 In Brief This Week: OpGen, Hologic, Exact Sciences, Thermo Fisher, and More Dec 28, 2020 COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 Dec 16, 2020 Sherlock Biosciences Receives $5M Gates Foundation Grant for COVID-19 Self-Test Dec 4, 2020 Sherlock Biosciences Licenses US Dx Rights to CRISPR-Cas12 From Tolo Biotech Nov 18, 2020 Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx Sep 21, 2020 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection Sep 17, 2020 In Brief This Week: Illumina, Siemens Healthineers, Danaher, Abbott, and More Breaking News European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal AnPac Bio to Raise $5M in Private Placement Top Five Articles on 360Dx Last Week: Sherlock Bio's $2M Award; Nostics' POC Testing Plans; and More KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
